These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3183943)

  • 1. Unnecessary alarm about lovastatin and cataracts.
    Schechter RJ
    J Cataract Refract Surg; 1988 Sep; 14(5):581-2. PubMed ID: 3183943
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular examination before initiation of lovastatin (Mevacor) therapy.
    Fraunfelder FT
    Am J Ophthalmol; 1988 Jan; 105(1):91-2. PubMed ID: 3337199
    [No Abstract]   [Full Text] [Related]  

  • 3. Lovastatin for hypercholesterolemia.
    Med Lett Drugs Ther; 1987 Nov; 29(752):99-101. PubMed ID: 3312981
    [No Abstract]   [Full Text] [Related]  

  • 4. Ocular side effects of the lipid-lowering drug simvastatin? A one year follow-up.
    Behrens-Baumann W; Morawietz A; Thiery J; Creutzfeldt C; Seidel D
    Lens Eye Toxic Res; 1989; 6(1-2):331-7. PubMed ID: 2488025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin and the human lens; results of a two year study. The MSDRL Study Group.
    Chylack LT; Mantell G; Wolfe JK; Friend J; Rosner B
    Optom Vis Sci; 1993 Nov; 70(11):937-43. PubMed ID: 8302530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia].
    Catalán M; López de Ocáriz A; Alvarez MP; Ariño M; Azanza JR; Honorato J
    Rev Med Univ Navarra; 1992; 37(3):127-33. PubMed ID: 1480917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Absence of cataractogenic effect of lovastatin (Mevinacor) so far].
    Ulbig M; Schneider T
    Fortschr Ophthalmol; 1991; 88(5):431-3. PubMed ID: 1757025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin and the human lens. Clinical results of a 3-year follow-up.
    Behrens-Baumann W; Thiery J; Wieland E; Fieseler HG; Seidel D
    Arzneimittelforschung; 1992 Aug; 42(8):1023-4. PubMed ID: 1418074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded clinical evaluation of lovastatin (EXCEL) study results. II. Assessment of the human lens after 48 weeks of treatment with lovastatin.
    Laties AM; Shear CL; Lippa EA; Gould AL; Taylor HR; Hurley DP; Stephenson WP; Keates EU; Tupy-Visich MA; Chremos AN
    Am J Cardiol; 1991 Mar; 67(6):447-53. PubMed ID: 1998274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin vs cholestyramine therapy for primary hypercholesterolemia.
    JAMA; 1988 Dec 23-30; 260(24):3590-1. PubMed ID: 3193586
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic use of lovastatin in the treatment of hypercholesterolemia.
    Illingworth DR
    Clin Ther; 1994; 16(1):2-26; discussion 1. PubMed ID: 8205598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lovastatin in the treatment of hypercholesterolemia].
    Adamska-Dyniewska H; Chojnowska-Jezierska J; Cybulska B; Grzymisławski M; Hryniewiecki L; Kaliciński A; Kawecka-Jaszcz K; Kleinrok A; Kłos ZJ; Kokot F
    Pol Arch Med Wewn; 1994 Jul; 92(1):54-62. PubMed ID: 7971478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pravastatin, simvastatin, and lovastatin for lowering serum cholesterol concentrations.
    Med Lett Drugs Ther; 1992 Jun; 34(872):57-8. PubMed ID: 1593973
    [No Abstract]   [Full Text] [Related]  

  • 15. No lens changes caused by simvastatin results from a prospective drug safety study.
    Schmidt J; Schmitt C; Hockwin O
    Lens Eye Toxic Res; 1990; 7(3-4):643-50. PubMed ID: 2100182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lovastatin alone and in combination for treatment of primary hypercholesterolemia.
    Stein EA; Lamkin GE; Bewley DZ
    Prog Clin Biol Res; 1988; 255():281-93. PubMed ID: 3340642
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma mevalonate response in lovastatin-related myopathy.
    Maher VM; Pappu A; Illingworth DR; Thompson GR
    Lancet; 1989 Nov; 2(8671):1098. PubMed ID: 2572817
    [No Abstract]   [Full Text] [Related]  

  • 18. Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study.
    Havel RJ; Hunninghake DB; Illingworth DR; Lees RS; Stein EA; Tobert JA; Bacon SR; Bolognese JA; Frost PH; Lamkin GE
    Ann Intern Med; 1987 Nov; 107(5):609-15. PubMed ID: 3662274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worldwide experience with simvastatin/lovastatin.
    Walker JF
    Eur Heart J; 1992 Jul; 13 Suppl B():21-2. PubMed ID: 1644097
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical efficacy and safety of lovastatin and MK-733--an overview.
    Walker JF; Tobert JA
    Eur Heart J; 1987 Aug; 8 Suppl E():93-6. PubMed ID: 3315683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.